Answers are grounded in this paper and cite their sources.
Naturally occurring polymorphisms at positions involved in resistance to antiretroviral agents are frequently seen in HIV-1 non-B subtypes. Although they do not seem to affect significantly the susceptibility to antiretroviral drugs in vitro, they may facilitate the selection of different pathways and/or a more rapid emergence of drug resistance and treatment failure under not fully suppressive treatment regimens.
No takes yet. Share an insight, caveat, or question.
A 2002 study studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: